首页 › 基金 › FRONTIER CAPITAL MANAGEMENT CO LLC › JAZZ
FRONTIER CAPITAL MANAGEMENT CO LLC 对 JAZZ 的持仓历史
JAZZ PHARMACEUTICALS PLC · 医疗保健
FRONTIER CAPITAL MANAGEMENT CO LLC 在 Q3 2026 的 13F 申报中披露持有 JAZZ(JAZZ PHARMACEUTICALS PLC)336,709 股,市值约 US$78.0M,约占其申报组合的 0.83%,在其申报持仓中市值排名第 23 位。 FRONTIER CAPITAL MANAGEMENT CO LLC 最近 13 个申报季度中有 13 个季度披露了 JAZZ 持仓,最早可追溯至 Q3 2023。
最后更新: 2026-11-17 · 来源: SEC EDGAR Form 13F-HR
FRONTIER CAPITAL MANAGEMENT CO LLC 对 JAZZ 的持仓演变
FRONTIER CAPITAL MANAGEMENT CO LLC 于 Q3 2023 首次披露 JAZZ 持仓:58,467 股(约 US$7.6M)。 该持仓在 Q1 2026 达到峰值 517,284 股,市值约 US$97.8M。 在 13 次申报中,FRONTIER CAPITAL MANAGEMENT CO LLC 6 次增持、5 次减持、1 次保持不变。 最近一期申报(Q3 2026)显示持股 336,709 股、市值约 US$78.0M,环比增持 59,430 股。。 持仓曾出现大幅变动:Q4 2025 增持约 373% (随后一个季度股价上涨 11%)、Q1 2026 增持约 184% (随后一个季度股价上涨 27%)、Q2 2026 减持约 46% (随后一个季度股价下跌 4%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2023 | 58.47K | $7.57M | 新进 |
| Q4 2023 | 59.84K | $7.36M | 增持 |
| Q1 2024 | 33.25K | $4.00M | 减持 |
| Q2 2024 | 24.42K | $2.61M | 减持 |
| Q3 2024 | 23.98K | $2.67M | 减持 |
| Q4 2024 | 35.00K | $4.31M | 增持 |
| Q1 2025 | 39.79K | $4.94M | 增持 |
| Q2 2025 | 39.67K | $4.21M | 持有 |
| Q3 2025 | 38.51K | $5.08M | 减持 |
| Q4 2025 | 182.20K | $30.97M | 增持 |
| Q1 2026 | 517.28K | $97.79M | 增持 |
| Q2 2026 | 277.28K | $66.82M | 减持 |
| Q3 2026 | 336.71K | $77.95M | 增持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 JAZZ 与 13F 数据
JAZZ(JAZZ PHARMACEUTICALS PLC)属于医疗保健行业。我们追踪的基金中还有 41 只申报持有 JAZZ,申报仓位最大的包括:FULLER & THALER ASSET MANAGEMENT, INC. (US$323.8M), Boston Trust Walden Corp (US$98.3M), Sofinnova Investments, Inc. (US$97.8M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 JAZZ 的基金
- FULLER & THALER ASSET MANAGEMENT, INC. 1.40M 股 · $323.77M · Q3 2026
- Boston Trust Walden Corp 424.57K 股 · $98.30M · Q3 2026
- Sofinnova Investments, Inc. 422.38K 股 · $97.79M · Q3 2026
- GOLDENTREE ASSET MANAGEMENT LP 421.94K 股 · $97.55M · Q3 2026
更多关于 FRONTIER CAPITAL MANAGEMENT CO LLC
常见问题
How long has FRONTIER CAPITAL MANAGEMENT CO LLC held JAZZ?
FRONTIER CAPITAL MANAGEMENT CO LLC has disclosed JAZZ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is FRONTIER CAPITAL MANAGEMENT CO LLC's current position in JAZZ?
As of Q3 2026, FRONTIER CAPITAL MANAGEMENT CO LLC holds 336.71K shares of JAZZ (JAZZ PHARMACEUTICALS PLC), valued at $77.95M, representing 0.83% of its reported portfolio and ranking #23.
Has FRONTIER CAPITAL MANAGEMENT CO LLC been buying or selling JAZZ?
In the latest 13F filing (Q3 2026), FRONTIER CAPITAL MANAGEMENT CO LLC increased its position in JAZZ. The position peaked in Q1 2026 at 517.28K shares.
Which other funds hold JAZZ?
Other major institutional holders of JAZZ include FULLER & THALER ASSET MANAGEMENT, INC., Boston Trust Walden Corp, Sofinnova Investments, Inc., among 41 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.